These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

115 related articles for article (PubMed ID: 5888981)

  • 21. [Experimental data to substantiate the antitumor action of hydrazine sulfate].
    Tret'iakov AV; Filov VA; Riazanov EM; Tarkov AS
    Vopr Onkol; 1979; 25(6):100-3. PubMed ID: 462860
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Effect of perfusing blood on serum protein oduction by isolated perfused livers from normal or tumor-bearing rats.
    Toporek M
    Cancer Res; 1969 Jun; 29(6):Suppl:1267-71. PubMed ID: 4183734
    [No Abstract]   [Full Text] [Related]  

  • 23. The metabolic disposition of [14C]pivhydrazine, [14C]mebanazine, and [14C]benzylhydrazine in the rat.
    Bolton GC; Griffiths LA
    Drug Metab Dispos; 1979; 7(6):388-92. PubMed ID: 43225
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Effect of 1,4-dihydropyridine and 1,6-dihydropyrimidine derivatives on energy metabolism of normal and tumor cells].
    Kumsar KK; Velena AKh; Dubur GIa; Uldrikis IaR; Zidermane AA
    Biokhimiia; 1971; 36(6):1204-9. PubMed ID: 5158730
    [No Abstract]   [Full Text] [Related]  

  • 25. Pharmacokinetics of [14C] BBR 3053, an alkylating bisphosphonate, after single i.v. and multiple s.c. administration in rats.
    Bernareggi A; Crippa MT; Bastrup U; Di Giovine S; Cesarini R; Tognella S
    Boll Chim Farm; 1997 Apr; 136(4):304-7. PubMed ID: 9281891
    [No Abstract]   [Full Text] [Related]  

  • 26. In vivo 31P MRS in new antineoplastic agents evaluation on experimental tumor models.
    Le Moyec L; Naruse S; Higuchi T; Hirakawa K; Watari H; de Certaines JD; Roques BP
    Cancer Biochem Biophys; 1988 Jul; 10(1):31-45. PubMed ID: 2465078
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Carbonyl derivatives of tilorone. Part 2: On the cancerostatic activity of carbonyl derivatives of tilorone (author's transl)].
    Schulze W; Letsch G; Gutsche W; Jungstand W; Wohlrabe K
    Pharmazie; 1979 Apr; 34(4):216-21. PubMed ID: 482327
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Some antitumor agents derived from benzaldehyde nitrogen mustards.
    Florvall L
    Acta Pharm Suec; 1970 Apr; 7(2):87-104. PubMed ID: 5421623
    [No Abstract]   [Full Text] [Related]  

  • 29. Distribution of new fluorene disulphonamido derivatives in rats with transplanted Walker carcinosarcoma.
    Malejka D
    Br J Cancer; 1966 Dec; 20(4):857-70. PubMed ID: 5964617
    [No Abstract]   [Full Text] [Related]  

  • 30. On the relationship between the activity of acetylation, growth of experimental tumors and efficacy of their suppression by hydrazine sulphate.
    Dilman VM; Anisimov VN; Kolosov AI; Bulovskaya LN
    Oncology; 1976; 33(5-6):219-21. PubMed ID: 1026855
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Pharmacological studies of the mechanism of tumor-induced bone marrow cytolysis.
    DiStefano JF; Lysik R; Zucker S
    Cancer Res; 1979 Apr; 39(4):1193-8. PubMed ID: 421203
    [No Abstract]   [Full Text] [Related]  

  • 32. [Correlation between copper and ceruloplasmin plasma concentration and 3 H-thymidine incorporation of Walker carcinosarcoma].
    Volm M; Wayss K; Wesch H; Zimmerer J
    Arch Geschwulstforsch; 1972; 40(6):248-58. PubMed ID: 4646752
    [No Abstract]   [Full Text] [Related]  

  • 33. Demethylation in vivo of Natulan, a tumour-inhibiting methylhydrazine derivative.
    Baggiolini M; Bickel MH; Messiha FS
    Experientia; 1965 Jun; 21(6):334-6. PubMed ID: 5870507
    [No Abstract]   [Full Text] [Related]  

  • 34. Clinical pharmacologic study of 1-acetyl-2-picolinoyl hydrazine (NSC-68626).
    Laszlo J; Durant J; Loeb V
    Cancer Chemother Rep; 1969 Apr; 53(2):131-4. PubMed ID: 4895097
    [No Abstract]   [Full Text] [Related]  

  • 35. [Temperature depending changes of 3H-TTP, 3H-TDP and 3H-TMP content in Walker's carcinosarcoma in external offer of 3H-thymidine].
    Wüst G; Buchholz B; Witting U; Norpoth K
    Verh Dtsch Ges Inn Med; 1973; 79():1384-6. PubMed ID: 4790192
    [No Abstract]   [Full Text] [Related]  

  • 36. [Characteristics of growth and sensitivity to cytostatics of Walker 256 carcinosarcoma in randombred and Wistar rats].
    Karaivanova MK
    Eksp Med Morfol; 1974; 13(4):237-42. PubMed ID: 4219353
    [No Abstract]   [Full Text] [Related]  

  • 37. Metabolism of 6-chloro-5-cyclohexylindane-1-carboxylic acid (TAI-284), a new non-steroidal anti-inflammatory agent. I. Absorption, distribution and excretion in rats.
    Tanayama S; Tsuchida E; Suzuoki Z
    Xenobiotica; 1973 Oct; 3(10):643-56. PubMed ID: 4774631
    [No Abstract]   [Full Text] [Related]  

  • 38. [Cytotoxic effect by a methylhydrazine compound].
    Zangger J
    Arzneimittelforschung; 1967 Apr; 17(4):511-3. PubMed ID: 5632453
    [No Abstract]   [Full Text] [Related]  

  • 39. [Ultrastructural changes in cells of the original tumors, metastases and stroma of rat walker-256 carcinosarcoma treated with a heparin complex with urea].
    Kolomina SM; Chentsov IuS; Pogodina LS; Kudriashov BA; Kalishevskaia TM
    Tsitol Genet; 1979; 13(1):8-15. PubMed ID: 442204
    [No Abstract]   [Full Text] [Related]  

  • 40. [Observations on the use of a recent antineoplastic drug (methylhydrazine) associated with radiotherapy].
    Agati G
    Minerva Radiol; 1968 Sep; 13(9):470-8. PubMed ID: 5726968
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.